IGF-I treatment improves the functional properties of fast- and slow-twitch skeletal muscles from dystrophic mice
- 1 April 2001
- journal article
- Published by Elsevier in Neuromuscular Disorders
- Vol. 11 (3) , 260-268
- https://doi.org/10.1016/s0960-8966(00)00192-9
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Skeletal muscle hypertrophy is mediated by a Ca2+-dependent calcineurin signalling pathwayNature, 1999
- IGF-1 induces skeletal myocyte hypertrophy through calcineurin in association with GATA-2 and NF-ATc1Nature, 1999
- Is there a future for gene therapy?Neuromuscular Disorders, 1999
- Association of IGF-I and IGF-II with myofiber regeneration in vivoMuscle & Nerve, 1999
- Preventive effects of insulinlike growth factor-I on steroid-induced muscle atrophyMuscle & Nerve, 1999
- Viral mediated expression of insulin-like growth factor I blocks the aging-related loss of skeletal muscle functionProceedings of the National Academy of Sciences, 1998
- Insulin-Like Growth Factor-I and High Protein Diet Decrease Calpain-Mediated Proteolysis in Murine Muscular DystrophyExperimental Biology and Medicine, 1998
- Metabolic and Structural Effects of Insulin-like Growth Factor-I and High-Protein Diet on Dystrophic Hamster Skeletal MuscleExperimental Biology and Medicine, 1997
- The Potential Role of Insulin-Like Growth Factors in Skeletal Muscle RegenerationCanadian Journal of Applied Physiology, 1996
- Endocrine regulation of protein breakdown in skeletal muscleDiabetes/Metabolism Research and Reviews, 1988